PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 13, 2026Movement Disorders2 citations

Stimulation and Medication Effects on Subthalamic Nucleus Beta‐Band Power in Parkinson's Disease: Implications for Adaptive Deep Brain Stimulation

View Full Paper
LHLauren H. HammerSCStephanie CerneraCOCarina R. Oehrn

Key Points

  • The research aims to explore how stimulation and medication affect beta oscillations in the subthalamic nucleus of Parkinson's disease patients.
  • Analyzed spectral characteristics of beta oscillations
  • Investigated effects of different stimulation conditions
  • Assessed medication influence on beta-band power
  • Beta oscillations in the subthalamic nucleus vary based on stimulation and medication
  • Findings support beta power as a biomarker for adaptive deep brain stimulation

Abstract

The spectral characteristics of STN beta oscillations and their performance as a biomarker in aDBS for Parkinson's disease are influenced by the stimulation and medication conditions in which it is implemented. © 2026 International Parkinson and Movement Disorder Society.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hammer et al. (2026) studied this question.

synapsesocial.com/papers/69b3aca302a1e69014cce75fhttps://doi.org/10.1002/mds.70261
Ask AI
Helpful
Bookmark
Share
View Full Paper